Relationship between human platelet antigen-1 gene polymorphism and clopidogrel resistance in patients with coronary artery disease

Relationship between human platelet antigen-1 gene polymorphism and clopidogrel resistance in patients with coronary artery disease

Objectives: It has been proposed that human platelet antigen- 1 (HPA-1) gene polymorphism is associated with coronary artery disease (CAD) and affects platelet function. We aimed to investigate the distribution of HPA gene polymorphism between angiographic CAD and a control group and the relation b...

Full description

Bibliographic Details
Main Authors:	İbrahim Halil Tanboğa, Mehmet Mustafa Can, Alper Özkan, Hacer Ceren Tokgöz, Taylan Akgün, Fatih Koca, Mustafa Kurt, Cihangir Kaymaz
Format:	Article
Language:	English
Published:	KARE Publishing 2013-07-01
Series:	Türk Kardiyoloji Derneği Arşivi
Subjects:	angioplasty balloon coronary/methods dose-response relationship drug; drug resistance; human platelet antigen-1; clopidogrel; percutaneous coronary intervention; polymorphism genetic; platelet aggregation/drug effects/genetics.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-97253

Similar Items

Resistência ao clopidogrel: prevalência e variáveis associadas
by: Fabrício Braga da Silva, et al.

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01)

Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study
by: Zekang Ye, et al.
Published: (2022-09-01)

Clopidogrel resistance and genetic factors
by: Alev Arat Özkan
Published: (2013-07-01)

The effectiveness, side effects and acceptability of locally available brand of Clopidogrel (Osvix) as antiplatelet tablet in CABG patients
by: Behzad Imani, et al.
Published: (2014-07-01)

Clinical and morphological evaluation of coronary bifurcation lesions
by: Mustafa Kurt, et al.
Published: (2013-05-01)

Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)
by: Meijiao He, et al.
Published: (2022-11-01)

Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation
by: Yalçın Velibey, et al.
Published: (2018-07-01)

Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview
by: C. D. Ramakrishna, et al.
Published: (2017-06-01)

Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study
by: Xiao-Fei Gao, et al.
Published: (2018-05-01)

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática Clinical relevance of clopidogrel and omeprazole interaction: systematic review
by: Héctor Holguín, et al.
Published: (2012-01-01)

Resistência ao clopidogrel: prevalência e variáveis associadas Resistance to clopidogrel: prevalence and associate variables
by: Fabrício Braga da Silva, et al.
Published: (2012-12-01)

Resistência ao clopidogrel: prevalência e variáveis associadas Resistance to clopidogrel: prevalence and associate variables
by: Fabrício Braga da Silva, et al.
Published: (2012-01-01)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
by: Jiawen Li, et al.
Published: (2021-10-01)

Impact of Scoring Balloon Angioplasty on Lesion Preparation for DCB Treatment of Coronary Lesions
by: Eun-Seok Shin, et al.
Published: (2023-09-01)

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
by: Berger Peter B
Published: (2000-10-01)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention FNx01
by: Seyed Hashemi Jazi, et al.
Published: (2011-01-01)

Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
by: Dongwhane Lee, et al.
Published: (2018-09-01)

Factors related to on-treatment platelet aggregation assessed by multiple electrode aggregometry in percutaneous coronary intervention patients on clopidogrel and aspirin
by: Krzysztof Kukula, et al.
Published: (2017-09-01)

Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6
by: Bin YANG, et al.
Published: (2020-02-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

Safety and Efficacy of an Innovative Everolimus-Coated Balloon in a Swine Coronary Artery Model
by: Christos S. Katsouras, et al.
Published: (2023-10-01)

Lotus root‐like appearance in the left anterior descending artery treated with a drug‐coated balloon angioplasty
by: Wataru Takagi, et al.
Published: (2022-07-01)

Intravascular Lithotripsy in Calcified Coronary Lesions: A Single-Center Experience in “Real-World” Patients
by: Angelo Mastrangelo, et al.
Published: (2022-02-01)

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
by: Naveen Seecheran, et al.
Published: (2019-07-01)

Platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor in comparison to clopidogrel: a retrospective pharmacodynamic analysis
by: Gerhard Selhorst, et al.
Published: (2019-04-01)

Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment
by: Shushu Yu, et al.
Published: (2023-07-01)

Clopidogrel use and smoking cessation result in lower coated-platelet levels after stroke
by: Angelia C. Kirkpatrick, et al.
Published: (2020-02-01)

The expression profile of platelet‐derived miRNA in coronary artery disease patients with clopidogrel resistance
by: Shaoyi Lin, et al.
Published: (2021-04-01)

Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease
by: Xiaolei Hu, et al.
Published: (2023-12-01)

The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
by: Zehao Zhao, et al.
Published: (2023-05-01)

Alta reatividade plaquetária durante tratamento é preditora de eventos cardíacos em pacientes com stents farmacológicos High on-treatment platelet reactivity predicts cardiac events in patients with drug-eluting stents
by: Aline Sterque Villacorta, et al.
Published: (2013-03-01)

Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
by: Zehao Zhao, et al.
Published: (2023-07-01)

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients
by: J.F.M. Marchini, et al.

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy
by: Zehao Zhao, et al.
Published: (2022-09-01)

New Antithrombotic Drugs in Acute Coronary Syndrome
by: Bastiaan Zwart, et al.
Published: (2020-06-01)

Clopidogrel therapy effects on cell hemostasis in acute coronary syndrome
by: R. A. Rakhimova, et al.
Published: (2008-12-01)